Scarica l'app Stockscreener
13.51
3.57%
-0.50
Dopo l'orario di chiusura:
13.51
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PRTA Giù?
Forum
Previsione
Precedente Chiudi:
$14.01
Aprire:
$14.02
Volume 24 ore:
680.55K
Relative Volume:
1.46
Capitalizzazione di mercato:
$726.46M
Reddito:
$217.25M
Utile/perdita netta:
$-50.92M
Rapporto P/E:
-9.5141
EPS:
-1.42
Flusso di cassa netto:
$-100.85M
1 W Prestazione:
-25.28%
1M Prestazione:
-21.04%
6M Prestazione:
-40.01%
1 anno Prestazione:
-60.33%
Intervallo 1D:
$13.45
$14.15
Intervallo di 1 settimana:
$13.45
$18.00
Portata 52W:
$13.45
$41.55
Prothena Corporation Plc Stock (PRTA) Company Profile
Nome
Prothena Corporation Plc
Settore
Industria
Telefono
011-353-1-236-2500
Indirizzo
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
Confronta PRTA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| PRTA | 13.51 | 726.46M | 217.25M | -50.92M | -100.85M | -1.42 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-01-30 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-12-12 | Iniziato | Deutsche Bank | Buy |
| 2023-04-24 | Iniziato | SVB Securities | Outperform |
| 2023-01-27 | Iniziato | Piper Sandler | Overweight |
| 2022-11-04 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-28 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-11-19 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-06-18 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-06-08 | Reiterato | Oppenheimer | Outperform |
| 2021-05-26 | Iniziato | Citigroup | Buy |
| 2021-02-26 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-02-12 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-02-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-12-07 | Iniziato | H.C. Wainwright | Buy |
| 2020-07-09 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2019-11-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-05-21 | Downgrade | Barclays | Equal Weight → Underweight |
| 2018-04-23 | Downgrade | Jefferies | Buy → Hold |
| 2018-04-05 | Reiterato | Barclays | Overweight |
| 2017-11-20 | Downgrade | Wedbush | Outperform → Neutral |
| 2017-09-29 | Reiterato | BTIG Research | Buy |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-08-17 | Iniziato | Evercore ISI | Outperform |
| 2017-07-11 | Iniziato | Jefferies | Buy |
| 2017-04-12 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-04-12 | Iniziato | Piper Jaffray | Overweight |
| 2017-03-02 | Iniziato | Instinet | Buy |
| 2016-12-21 | Iniziato | SunTrust | Buy |
| 2016-11-03 | Iniziato | Deutsche Bank | Buy |
| 2016-08-04 | Reiterato | Barclays | Overweight |
| 2016-05-13 | Iniziato | Barclays | Overweight |
| 2016-02-19 | Reiterato | Wedbush | Outperform |
| 2016-01-21 | Iniziato | Credit Suisse | Outperform |
Mostra tutto
Prothena Corporation Plc Borsa (PRTA) Ultime notizie
Prothena FY2024 EPS Forecast Raised by Cantor Fitzgerald - Defense World
FY2024 EPS Estimates for Prothena Cut by HC Wainwright - MarketBeat
Prothena (NASDAQ:PRTA) Hits New 12-Month LowHere's What Happened - MarketBeat
Prothena Co. plc (NASDAQ:PRTA) Receives $61.86 Average PT from Brokerages - Defense World
FY2028 EPS Estimates for Prothena Increased by HC Wainwright - MarketBeat
Prothena's SWOT analysis: stock poised for potential breakthroughs amid risks - Investing.com India
Expert Ratings For Prothena Corp - Benzinga
Prothena's (PRTA) Buy Rating Reiterated at HC Wainwright - MarketBeat
Prothena (NASDAQ:PRTA) Announces Quarterly Earnings Results, Beats Estimates By $0.08 EPS - MarketBeat
Prothena Q3 Earnings Beat Estimates, Pipeline Progress in Focus - Yahoo Finance
Prothena Reports Third Quarter 2024 Financial Results and Business Highlights - BioSpace
Prothena (PRTA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Canada Finance
Prothena: Q3 Earnings Snapshot - Marketscreener.com
Prothena Corp PLC Reports Q3 2024 EPS Loss of $1.10, Beats Estimate; Revenue Misses at $1.0 Million - GuruFocus.com
Prothena Corporation plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Prothena Co. plc (NASDAQ:PRTA) Receives $61.86 Average Target Price from Brokerages - MarketBeat
Creative Planning Invests $350,000 in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Wellington Management Group LLP's Strategic Acquisition in Proth - GuruFocus.com
Prothena (PRTA) Scheduled to Post Earnings on Tuesday - MarketBeat
Prothena to Report Third Quarter 2024 Financial Results on November 12 - The Bakersfield Californian
Long Term Trading Analysis for (PRTA) - Stock Traders Daily
Prothena (NASDAQ:PRTA) Stock Price Up 5.7%Here's Why - MarketBeat
Prothena (PRTA) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Strength Seen in Prothena (PRTA): Can Its 15.0% Jump Turn into More Strength? - Yahoo Finance
Prothena (NASDAQ:PRTA) Shares Gap UpShould You Buy? - MarketBeat
Prothena's SWOT analysis: stock poised for growth amid clinical milestones - Investing.com
Prothena Co. plc (NASDAQ:PRTA) Short Interest Up 28.1% in October - MarketBeat
Prothena (NASDAQ:PRTA) Sets New 12-Month LowHere's What Happened - MarketBeat
When (PRTA) Moves Investors should Listen - Stock Traders Daily
SG Americas Securities LLC Sells 40,485 Shares of Prothena Co. plc (NASDAQ:PRTA) - MarketBeat
Analysts Set Prothena Co. plc (NASDAQ:PRTA) Target Price at $61.86 - Defense World
State Street Corp's Strategic Reduction in Prothena Corp PLC Hol - GuruFocus.com
Prothena: Delays And Data Uncertainty Undermine Case For Investing (Downgrade) (PRTA) - Seeking Alpha
Prothena Co. plc (NASDAQ:PRTA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Prothena (NASDAQ:PRTA) Stock Price Crosses Below 200 Day Moving AverageHere's What Happened - MarketBeat
Tau Inhibitors Clinical Trial Pipeline Analysis Demonstrates 25+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - GlobeNewswire Inc.
(PRTA) Long Term Investment Analysis - Stock Traders Daily
Is Prothena Corporation plc (PRTA) worth investing in despite its undervalued state? - US Post News
Holdings of Prothena Corporation plc (PRTA) are aligned with the stars - SETE News
Daily Progress: Prothena Corporation plc (PRTA) Gain 0.36, Closing at 16.86 - The Dwinnex
Dimensional Fund Advisors LP Reduces Holdings in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Duncan Williams Asset Management LLC Makes New Investment in Prothena Co. plc (NASDAQ:PRTA) - MarketBeat
Algert Global LLC Acquires 28,841 Shares of Prothena Co. plc (NASDAQ:PRTA) - Defense World
Nothing is Better Than Prothena Corporation plc (PRTA) stock at the moment - SETE News
(PRTA) On The My Stocks Page - Stock Traders Daily
Prothena Corporation plc (NASDAQ:PRTA) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough - Simply Wall St
PRTA’s price-to-sales ratio: A comparative analysis with its peers - US Post News
Prothena Corporation plc (PRTA) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
Breaking Down Prothena Corp: 4 Analysts Share Their Views - Benzinga
Prothena shares hold buy rating with steady target amid selloff By Investing.com - Investing.com UK
Prothena (NASDAQ:PRTA) Stock Rating Reaffirmed by HC Wainwright - MarketBeat
Prothena Corporation Plc Azioni (PRTA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):